Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Centene Corp

Healthcare US CNC

36.4USD
-6.92(15.97%)

Last update at 2026-03-10T20:27:00Z

Day Range

36.2742.47
LowHigh

52 Week Range

55.0381.42
LowHigh

Fundamentals

  • Previous Close 43.32
  • Market Cap28630.89M
  • Volume18086182
  • P/E Ratio9.79
  • Dividend Yield-%
  • EBITDA5919.00M
  • Revenue TTM146204.00M
  • Revenue Per Share TTM275.74
  • Gross Profit TTM 24470.00M
  • Diluted EPS TTM5.79

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 3598.00M 1962.00M 1813.00M 2773.00M 1782.00M
Minority interest 3.00M 3.00M 11.00M -14.00000M -12.00000M
Net income 2702.00M 1202.00M 1347.00M 1808.00M 1321.00M
Selling general administrative 12273.00M 20919.00M 10166.00M 11343.00M 6533.00M
Selling and marketing expenses - - - - -
Gross profit 31541.00M 16656.00M 14199.00M 15216.00M 8843.00M
Reconciled depreciation 1452.00M 1553.00M 1476.00M 1259.00M 643.00M
Ebit 2930.00M 2627.00M 2478.00M 3501.00M 1781.00M
Ebitda 2930.00M 4058.00M 3954.00M 4760.00M 2695.00M
Depreciation and amortization 1293.00M 1431.00M 1476.00M 1259.00M 914.00M
Non operating income net other - 1279.00M 819.00M 480.00M 413.00M
Operating income 2930.00M 3636.00M 3263.00M 3082.00M 1781.00M
Other operating expenses 151069.00M 140911.00M 122719.00M 107961.00M 72587.00M
Interest expense 725.00M 665.00M 665.00M 728.00M 412.00M
Tax provision 1174.00M 760.00M 477.00M 979.00M 473.00M
Interest income - 665.00M 665.00M 728.00M 412.00M
Net interest income -716.00000M -665.00000M -665.00000M -728.00000M -412.00000M
Extraordinary items - - - - 0.00000M
Non recurring - 2318.00M 1479.00M 72.00M 271.00M
Other items - - - - -
Income tax expense 899.00M 760.00M 477.00M 979.00M 473.00M
Total revenue 153999.00M 144547.00M 125982.00M 111115.00M 74639.00M
Total operating expenses 28611.00M 13020.00M 10936.00M 12062.00M 6791.00M
Cost of revenue 122458.00M 127891.00M 111783.00M 95899.00M 65796.00M
Total other income expense net 668.00M 644.00M 29.00M -309.00000M 1.00M
Discontinued operations - - - - -
Net income from continuing ops 2441.00M 1202.00M 1336.00M 1794.00M 2255.00M
Net income applicable to common shares - 1202.00M 1347.00M 1808.00M 1321.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 84641.00M 76870.00M 78375.00M 68719.00M 40994.00M
Intangible assets 6101.00M 6911.00M 7824.00M 8388.00M 2063.00M
Earning assets - - - - -
Other current assets 21104.00M 2461.00M 1602.00M 1317.00M 1090.00M
Total liab 58685.00M 52633.00M 51353.00M 42757.00M 28302.00M
Total stockholder equity 25840.00M 24057.00M 26795.00M 25773.00M 12551.00M
Deferred long term liab - - - - -
Other current liab 19294.00M 18379.00M 16571.00M 13896.00M 8297.00M
Common stock 1.00M 1.00M 1.00M 1.00M 0.00000M
Capital stock 1.00M 1.00M 1.00M 1.00M 0.00000M
Retained earnings 12043.00M 9341.00M 8139.00M 6792.00M 4984.00M
Other liab - 3098.00M 7017.00M 4490.00M 1099.00M
Good will 17558.00M 18812.00M 19771.00M 18652.00M 6863.00M
Other assets - 1217.00M 4849.00M 2659.00M 1236.00M
Cash 17193.00M 12074.00M 13118.00M 10800.00M 12123.00M
Cash and equivalents - 12074.00M 13118.00M 10800.00M 12123.00M
Total current liabilities 36716.00M 28464.00M 25765.00M 21585.00M 12932.00M
Current deferred revenue 715.00M 478.00M 434.00M 523.00M 383.00M
Net debt 1684.00M 5946.00M 5720.00M 5979.00M 1603.00M
Short term debt 287.00M 82.00M 267.00M 97.00M 88.00M
Short long term debt 119.00M 82.00M 267.00M 97.00M 88.00M
Short long term debt total 18877.00M 18020.00M 18838.00M 16779.00M 13726.00M
Other stockholder equity 14448.00M 15847.00M 18578.00M 18643.00M 7433.00M
Property plant equipment - 2432.00M 3391.00M 2774.00M 2121.00M
Total current assets 40756.00M 30128.00M 28497.00M 23393.00M 20323.00M
Long term investments 16286.00M 14684.00M 14043.00M 12853.00M 7717.00M
Net tangible assets - -1610.00000M -800.00000M -1190.00000M 3658.00M
Short term investments 2459.00M 2321.00M 1539.00M 1580.00M 863.00M
Net receivables 15532.00M 13272.00M 12238.00M 9696.00M 6247.00M
Long term debt 17710.00M 17938.00M 18571.00M 16682.00M 13638.00M
Inventory -35184.00000M - - - -
Accounts payable 16252.00M 9525.00M 8493.00M 7069.00M 4164.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 124.00M 145.00M 112.00M 108.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -652.00000M -1132.00000M 77.00M 337.00M 134.00M
Additional paid in capital - - - - -
Common stock total equity - 1.00M 1.00M 1.00M -
Preferred stock total equity - - - - -
Retained earnings total equity - 9341.00M 8139.00M 6792.00M 4984.00M
Treasury stock - -4213.00000M -1094.00000M -816.00000M -214.00000M
Accumulated amortization - - - - -
Non currrent assets other 1525.00M 3903.00M 4849.00M 2659.00M 1907.00M
Deferred long term asset charges - - - - -
Non current assets total 43885.00M 46742.00M 49878.00M 45326.00M 20671.00M
Capital lease obligations 1048.00M 3313.00M - 1538.00M -
Long term debt total - 17938.00M 18571.00M 16682.00M 13638.00M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -21.00000M -2921.00000M -3299.00000M -2481.00000M -766.00000M
Change to liabilities - 3660.00M 1032.00M 2780.00M 342.00M
Total cashflows from investing activities - -2921.00000M -3299.00000M -6955.00000M -1532.00000M
Net borrowings - -1144.00000M 1833.00M 839.00M 6870.00M
Total cash from financing activities -1658.00000M -4197.00000M 1362.00M 260.00M 6832.00M
Change to operating activities - 3369.00M 2797.00M 2190.00M 504.00M
Net income 2702.00M 1202.00M 1336.00M 1794.00M 1309.00M
Change in cash 5122.00M -884.00000M 2257.00M -1174.00000M 6781.00M
Begin period cash flow 12330.00M 13214.00M 10957.00M 12131.00M 5350.00M
End period cash flow 17452.00M 12330.00M 13214.00M 10957.00M 12131.00M
Total cash from operating activities 8053.00M 6261.00M 4205.00M 5503.00M 1483.00M
Issuance of capital stock 40.00M 70.00M 35.00M 0.00000M 0.00000M
Depreciation 1293.00M 1553.00M 1476.00M 1259.00M 643.00M
Other cashflows from investing activities - -1917.00000M 19.00M -3605.00000M -36.00000M
Dividends paid 88.00M - 35.00M - -
Change to inventory 2122.00M - -1141.00000M -585.00000M 421.00M
Change to account receivables -2380.00000M -1627.00000M -2453.00000M -52.00000M -1076.00000M
Sale purchase of stock -1633.00000M -3096.00000M -297.00000M -626.00000M -75.00000M
Other cashflows from financing activities -88.00000M -41.00000M -174.00000M -73.00000M 24733.00M
Change to netincome - 1314.00M 6.00M 280.00M 508.00M
Capital expenditures 799.00M 1004.00M 910.00M 869.00M 730.00M
Change receivables - -1627.00000M -2453.00000M -52.00000M -1076.00000M
Cash flows other operating - 159.00M -208.00000M -558.00000M -243.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes - -857.00000M 2268.00M -1192.00000M 6783.00M
Change in working capital 3374.00M 2194.00M 1376.00M 2195.00M -1002.00000M
Stock based compensation 216.00M 234.00M 203.00M 281.00M 177.00M
Other non cash items 546.00M 1709.00M -54.00000M 25.00M 301.00M
Free cash flow 7254.00M 5257.00M 3295.00M 4634.00M 753.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNC
Centene Corp		 -6.92 15.97% 36.40 9.79 8.06 0.20 1.08 0.18 5.02
UNH
UnitedHealth Group Incorporated		 -2.83 0.99% 282.34 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 1.94 0.69% 282.68 18.00 12.66 0.65 2.87 0.74
CVS
CVS Health Corp		 -1.94 2.48% 76.32 12.06 9.08 0.29 1.34 0.47 8.96
CI
Cigna Corp		 -7.22 2.68% 262.44 30.25 10.09 0.39 2.10 0.50

Reports Covered

Stock Research & News

View All

Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corp

Centene Plaza, Saint Louis, MO, United States, 63105

Key Executives

Name Title Year Born
Ms. Sarah M. London Chief Exec. Officer & Director 1981
Mr. Brent Davis Layton Pres & COO 1968
Mr. Andrew Lynn Asher Exec. VP & CFO 1969
Mr. Christopher Andrew Koster Exec. VP, Gen. Counsel & Sec. 1965
Mr. Michael Frederic Neidorff Chairman (Leave of Absence) 1943
Ms. Katie Nicole Casso Sr. VP, Chief Accounting Office & Corp. Controller 1982
Mr. Mark J. Brooks Exec. VP & Chief Information Officer 1970
Ms. Shannon Bagley Exec. VP & Chief Admin. Officer 1979
Ms. Jennifer Lynch Gilligan Sr. VP of Investor Relations NA
Ms. Ashlee Knuckey Chief Ethics & Compliance Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.